Stryker
Pairs orthopaedic implants with Mako robotics, surgical equipment and vascular devices.
$334.18
After-hours close+3.50 (+1.06%)
At close$330.68(+2.66%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 123.28%Insiders 0.73%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 383.36M · Float 347.76M · 90.7% free float
Institutions13F, as of Jun 30, 2026
2,323 holders · 472.61M shares · 178 new positions · 1,106 increased · 856 reduced · 215 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 27.41M | 7.15% | −187.3K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 22.54M | 5.88% | +153.7K | Aug 13, 2026 |
| JPMorgan Chase & Co | 17.26M | 4.50% | +1.66M | Aug 12, 2026 |
| State Street Corp | 15.53M | 4.05% | +183.4K | Aug 7, 2026 |
| Greenleaf Trust | 15.23M | 3.97% | −709.5K | Jul 21, 2026 |
| Price T Rowe Associates Inc /MD/ | 11.92M | 3.11% | +1.88M | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 8.17M | 2.13% | −161.1K | Aug 13, 2026 |
| Wellington Management Group LLP | 8.17M | 2.13% | +45.5K | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 6.73% | 25.80M | 13G | Apr 30, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Ronda E. Stryker | director | 2.25M | 0.59% | Aug 20, 2026 |
| Kevin Lobo | director, officer: Chair and CEO | 222.2K | 0.06% | Mar 24, 2026 |
| James Andrew Pierce | officer: Group President | 81.6K | 0.02% | Mar 24, 2026 |
| Spencer S. Stiles | officer: President and COO | 77.5K | 0.02% | Jun 2, 2026 |
| Yin C. Becker | officer: VP, Chief Corp Affairs Officer | 33.7K | 0.01% | Mar 25, 2025 |
| Andrew K. Silvernail | director | 18.5K | 0.00% | May 8, 2026 |
| Viju Menon | officer: Group President | 17.4K | 0.00% | Mar 24, 2026 |
| M. Kathryn Fink | officer: VP, Chief HR Officer | 13.2K | 0.00% | Aug 4, 2026 |
| Glenn S. Boehnlein | officer: VP, Chief Financial Officer | 11.6K | 0.00% | Mar 25, 2025 |
| Dylan Bram Crotty | officer: Group President | 11.6K | 0.00% | Aug 26, 2026 |
3 ten-percent owners hold 7.39M shares by Form 4, outside the officers-and-directors figure above · 20 people have not refiled in the last 18 months (1.96M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 21, 2026 | Dylan Bram Crottyofficer: Group President | Sale | 441 | $328.61 | 6,102 |
| Aug 19, 2026 | Ronda E. Strykerdirector | Sale · 12 lots | 50,000 | $340.10 | 2,251,375 |
| Aug 18, 2026 | Ronda E. Strykerdirector | Sale · 8 lots | 300,000 | $335.90 | 2,301,375 |
| Aug 18, 2026 | Debra Kingofficer: See Remarks | Sale | 826 | $336.30 | 6,210 |
| May 28, 2026 | Robert S. Fletcherofficer: VP, Chief Legal Officer | Sale · 6 lots | 4,544 | $306.87 | 10,582 |
| May 26, 2026 | Ronda E. Strykerdirector | Sale · 6 lots | 310,000 | $312.23 | 1,924,880 |
| May 11, 2026 | M. Kathryn Finkofficer: VP, Chief HR Officer | Sale · 2 lots | 8,720 | $283.69 | 13,314 |
| Feb 5, 2026 | Ronda E. Strykerdirector | Sale · 7 lots | 250,000 | $363.95 | 2,207,331 |
| Feb 4, 2026 | Ronda E. Strykerdirector | Sale · 11 lots | 250,000 | $362.92 | 2,457,331 |
| Feb 2, 2026 | James Andrew Pierceofficer: Group President | Sale | 475 | $368.87 | 70,563 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Thomas H. Kean · NJ07 | Sale | $1,001 – $15,000 | Jul 22, 2026 | Aug 19, 2026 ↗ | |
| Sen. Alan Armstrong | Sale | $15,001 – $50,000 | Joint | Mar 27, 2026 | Jul 21, 2026 ↗ |
| Rep. Thomas H. Kean · NJ07 | Sale | $1,001 – $15,000 | Jun 2, 2026 | Jul 16, 2026 ↗ | |
| Rep. Ro Khanna · CA17 | Purchase | $15,001 – $50,000 | Spouse | Apr 13, 2026 | May 13, 2026 ↗ |